Abstract
This work identifies CD8-NOS2+COX2+ and CD8-NOS2-COX2+ unique cellular neighborhoods that drive the tumor immune spatial architecture of CD8+ T cells predictive of clinical outcome and can be targeted with clinically available NOS inhibitors and NSAIDs.
©2024 The Authors; Published by the American Association for Cancer Research.
MeSH terms
-
Animals
-
Breast Neoplasms* / immunology
-
Breast Neoplasms* / pathology
-
CD8-Positive T-Lymphocytes* / immunology
-
Cyclooxygenase 2* / metabolism
-
Female
-
Humans
-
Mice
-
Neoplasm Metastasis
-
Neoplastic Stem Cells* / drug effects
-
Neoplastic Stem Cells* / immunology
-
Neoplastic Stem Cells* / pathology
-
Nitric Oxide Synthase Type II* / metabolism
-
Receptors, Estrogen / metabolism
-
Stem Cell Niche
-
Tumor Microenvironment / immunology
Substances
-
Cyclooxygenase 2
-
Nitric Oxide Synthase Type II
-
NOS2 protein, human
-
Receptors, Estrogen
-
PTGS2 protein, human